Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$14.35 USD
+0.13 (0.91%)
Updated May 3, 2024 04:00 PM ET
After-Market: $14.34 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Brokerage Reports
Sabra Healthcare REIT, Inc. [SBRA]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Resistance at $14.50 and the Keys to Breaking Through;Reiterate Outperform
Provider: Wedbush Securities Inc.
Analyst: ANDERSON R
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Optimized Entry and Exit Levels for SBRA 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Health Care REIT Wrap: Third Quarter''s Senior Moments
Provider: Wedbush Securities Inc.
Analyst: ANDERSON R
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
In-Line 3Q23; Senior Housing Fundamentals Reaccelerate in 3Q, but Behavioral Segment Raises Questions
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
US Real Estate Investment Trusts (REITs) - Initiating Coverage Of The US REITs
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
We are initiating coverage of the US Real Estate Investment Trust (REIT) industry
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Fundamentals Improving, but Tenant Challenges Persist; Investment Landscape Remains Mixed
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
In-Line 2Q23; IL Occup. Headwinds Pause SHOP Improvement but New Disclosure Quantifies SHOP Upside
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Walking Away from Enlivant JV and Transitioning Wholly Owned Assets; SH Growth Shines
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
4Q22 Beat; Portfolio Holds Relatively Stable in 4Q, as Operating Statistics Improve
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Sabra Healthcare REIT, Inc.
Industry: REIT and Equity Trust - Other
Healthcare REITs: Updating Estimates and Price Targ
Provider: KeyBanc Capital Markets
Analyst: Research Department